Free Trial
ASX:CYP

Cynata Therapeutics (CYP) Stock Price, News & Analysis

About Cynata Therapeutics Stock (ASX:CYP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
159,853 shs
Average Volume
N/A
Market Capitalization
A$57.60 million
P/E Ratio
N/A
Dividend Yield
13.95%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cynata Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CYP Stock News Headlines

Cynata Therapeutics Ltd (51S.SG) - Yahoo Finance
Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.
See More Headlines

CYP Stock Analysis - Frequently Asked Questions

Cynata Therapeutics Limited (ASX:CYP) posted its quarterly earnings data on Wednesday, February, 27th. The company reported ($0.03) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.03). Cynata Therapeutics had a negative net margin of 420.82% and a negative trailing twelve-month return on equity of 100.01%.

Company Calendar

Last Earnings
2/27/2019
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:CYP
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$9.74 million
Net Margins
-420.82%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$2.32 million
Price / Cash Flow
11.93
Book Value
A$0.04 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$57.60 million
Optionable
Not Optionable
Beta
0.93
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (ASX:CYP) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners